Showing results (131-140 of 405) with videos related to

Sort By:
Pageof 41
Journal of Endourology|April 7, 2011
Impact of cold and warm ischemia on postoperative recovery of affected renal function after partial nephrectomyKatsunori Tatsugami, Masatoshi Eto, Akira Yokomizo, et al.
European Journal of Immunology|December 25, 2010
IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancerArio Takeuchi, Takashi Dejima, Hisakata Yamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 20, 2008
Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinomaKatsunori Tatsugami, Masatoshi Eto, Masahiko Harano, et al.
International Journal of Oncology|July 3, 2010
Sensitivity of doxorubicin-resistant cells to sorafenib: possible role for inhibition of eukaryotic initiation factor-2alpha phosphorylationMasaki Shiota, Masatoshi Eto, Akira Yokomizo, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2011
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppressionArio Takeuchi, Masaki Shiota, Katsunori Tatsugami, et al.
Annals of Surgical Oncology|January 16, 2026
Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder CancerTakahiko Hajime, Masaki Shiota, Genshiro Fukuchi, et al.
Endocrine-Related Cancer|February 23, 2017
Protein kinase C regulates Twist1 expression via NF-κB in prostate cancerMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.
Anticancer Research|July 5, 2018
Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate CancerTomohiko Murakami, Hirofumi Obata, Naoko Akitake, et al.
Urologia Internationalis|June 3, 2020
Tadalafil Improves Nocturia and Nocturia-Related Quality of Life in Patients with Benign Prostatic Hyperplasia (KYU-PRO Study)Ryosuke Takahashi, Yasuhiro Sumino, Minoru Miyazato, et al.
BJC Reports|July 24, 2025
Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomyQingjiang Hu, Yasue Kimura, Shinichiro Ikeda, et al.
Pageof 41